J Med Cases
Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website http://www.journalmc.org

Case Report

Volume 4, Number 4, April 2013, pages 234-236


VIP-Secreting Ganglioneuroblastoma as an Unusual Cause of Watery Diarrhoea in Childhood

Koen Huysentruyta, Wim Artsb, c, Jutte van der Werff ten Boscha, Willy Van de Casseyeb, Francis Lemmensb, Jan De Kosterb, Yvan Vandenplasa, An Van Dammea

aDepartment of Pediatrics, University Hospital, Brussels Free University, Brussels, Belgium
bDepartment of Pediatrics, Ziekenhuis Oost-limburg, Genk, Belgium
cCorresponding author: Wim Arts, Department of Pediatrics, Ziekenhuis Oost-limburg, Schiepse Bos 6, 3600 Genk, Belgium

Manuscript accepted for publication January 2, 2013
Short title: VIP-Secreting Ganglioneuroblastoma
doi: https://doi.org/10.4021/jmc1009w

Abstract▴Top 

A 15-month-old boy with a 2-month history of watery diarrhoea presented with cachexia, hypokalaemia, hypochloraemia and metabolic acidosis. During a 2-week investigation period infection, celiac disease and cystic fibrosis were excluded and trial therapy with antibiotics, probiotics and dietary measures proved unsuccessful. This led to the suspected diagnosis of a vasoactive intestinal polypeptide (VIP)-secreting tumour with watery diarrhoea, hypokalaemia, achlorhydria (WDHA)-syndrome. MRI showed an infrarenal mass infiltrating the neuroforamen, which on pathological examination was consistent with a VIP-secreting neuroganglioblastoma. Serum VIP and urinary catecholamine levels were elevated. Treatment consisted of 2 courses of chemotherapy and a partial resection of the tumour, following which the diarrhoea disappeared. Refractory watery diarrhoea that persists during fasting in a young child should alert to the diagnosis of WDHA, and prompt investigations to diagnose a VIP-secreting tumour, one of the most common causes of secretory diarrhoea in the developed world. Timely diagnosis could avoid morbidity due to unnecessary investigations and protracted diarrhoea.

Keywords: Child; Ganglioneuroblastoma; Neuroblastoma; Secretory diarrhoea; Vasoactive intestinal polypeptide; Vipoma; WDHA syndrome

Introduction▴Top 

A syndrome of profuse watery diarrhoea, hypokalaemia and achlorhydria was first described by Verner and Morrison in 1958 in 2 adults with a non-beta islet cell adenoma [1]. Bloom et al where the first to link this condition with high serum vasoactive intestinal polypeptide (VIP) levels in 5 patients with a pancreatic tumour, but also in a case was with a ganglioneuroblastoma [2]. The syndrome was later also called ‘vipoma syndrome’, or ‘watery diarrhoea, hypochloremia and acidosis syndrome’ (WDHA), since it is now generally agreed that achlorhydria is not an essential part of the syndrome and that hypochlorhydria or even normal chlorhydric levels may exist [3, 4]. In children WDHA is very rare, and although excessive VIP secretion is well described in neuroblastic tumours, it occurs in less than 1% of cases [5, 6]. We will discuss that the rareness of vipoma-induced WDHA in childhood renders diagnosis difficult, leading to unnecessary investigations, a delay in diagnosis and increased morbidity in these children. We will also point out some important clues that could lead to a more timely diagnosis.

Case Report▴Top 

A 15-month-old boy presented with a two-month history of watery diarrhoea with no other associated symptoms. Treatment had consisted of oral rehydration solution during exacerbations while probiotic and antibiotic therapy remained without effect. The boy was born at 36 weeks gestation (birth weight 2.650 kg). There was no family history of any intestinal or endocrine disorders. He was fed on formula milk since the age of 2 weeks; vegetables were introduced at the age of 3.5 months, fruits at 4.5 and gluten at 9 months. He had received all standard childhood immunizations.

When the child’s weight deviated from the 25th to the 3rd centile, he was hospitalized for further investigations. On admission, clinical exam showed a pale and cachectic toddler, with a soft and non-tender abdomen without organomegaly, distension or palpable masses. Further systemic examination revealed no anomalies. Blood pressure was 114/57 mmHg (> 99th centile). Lab analysis showed hypokalaemia (2.4 mmol/L), hypochlorhydria (96 mmol/L) and metabolic acidosis (bicarbonate 10 mmol/L); sodium levels were normal. Haemoglobin was 12.2 g/dL; total white cell count 18.6 × 109/L and platelet count 937 × 109/L; ESR was 56 mm/h. The total serum IgA level was normal. Repeated stool examinations were negative for pathogenic bacteria or viruses. Abdominal ultrasound was normal. Gastroscopy showed no abnormalities. Apart from subtle intra-epithelial lymphocytosis, a small-bowel biopsy was unremarkable and with anti-tissue transglutaminase antibodies being negative, celiac disease was ruled out. A left colonoscopy showed macro- and microscopically normal findings. Cystic fibrosis genotyping (InnoLipa CFTR19, CFTR17+Tn Update) showed no mutation. During the course of the investigations, dietary elimination of cow’s milk protein and lactose was ineffective. With common causes of chronic diarrhoea being ruled out, the persistence of watery diarrhoea raised the suspicion of a VIP-secreting tumour. Urine Dopamine and HVA were elevated (8,643 µg/g Cr and 39.7 mg/g Cr respectively), whilst urine VMA was normal (14.4 mg/g Cr). Serum-VIP level was significantly elevated (187 pg/mL). MRI showed a right-sided infrarenal mass infiltrating the neuroforamen (L3-L4) with a mass effect on the spinal cord (Fig. 1), and pathology of a biopsy confirmed the diagnosis of a VIP-secreting ganglioneuroblastoma. In view of massive intraspinal infiltration, the boy received 2 courses of chemotherapy (Carboplatinum, VP16), failing to result in shrinkage of tumour. Subtotal resection of the tumour was performed. Diarrhoea transiently improved after each chemotherapy course, and fully disappeared after surgery. One year after surgery, catch-up growth and weight gain has occurred to the 25th and 3rd centile respectively.

Figure 1.
Click for large image
Figure 1. MRI of the lumbal region showing a paravertebral mass infiltrating the spinal channel.
Discussion▴Top 

This case is illustrated how the rarity of the WDHA syndrome may lead to an initial denial of the diagnosis, even by experienced paediatric gastro-enterologists, and that a normal abdominal ultrasound may offer a false reassurance.

Chronic diarrhoea in childhood is not uncommon, and may result from a wide range of gastrointestinal disorders. The etiologies of chronic diarrhoea in childhood can be divided into four often overlapping pathophysiology mechanisms: osmotic, secretory, dysmotility-associated and inflammatory diarrhoea. True secretory diarrhoea concerns only a small proportion these cases and is the only type where diarrhoea persists even during prolonged fasting. A low stool osmotic gap (290- calculated stool osmolality = stool osmotic gap) is also a major hallmark of secretory diarrhoea, whereas a high stool osmolality and cessation of diarrhoea with elimination of the offending solute from the diet are specific for osmotic diarrhoea. Bloody stools and pathogens are seen in inflammatory diarrhoea. Dysmotility-associated diarrhoea (for example, toddler’s diarrhoea) is harder to prove and is often a diagnosis of exclusion.

The large time gap between onset of diarrhoea and diagnosis of the tumour is supported by findings from 2 retrospective studies on vipoma cases in childhood. In a review of 6 patients, Murphy et al reported a median hospital stay for investigations of 4 weeks, while the interval between referral and eventual diagnosis ranged from 1 to 10 months; diarrhoea persisted for a median duration of 5 months, and 5 children were severely malnourished at the time of diagnosis [7]. These findings are consistent with those of Bourdeaut et al in a series of 22 children with VIP-secreting neuroblastic tumours [5]. Likewise, our patient’s hospital stay was 2 weeks, and the definitive diagnosis was obtained 3 months after start of the diarrhoea.

We propose set of clinical features that may facilitate early diagnosis of vipoma in childhood. First, although WDHA has been described at various ages, it appears to be more common in infants and young children. The median age of presentation was 21 months in the Iida study, 18 months in the Bourdeaut study, and all cases described by Murphy et al were 24 months or younger [5, 7, 8]; our patient also falls in this age category. Second, chronic watery diarrhoea refractory to fasting and total parenteral nutrition during 48 to 72 hours should alert to the diagnosis of secretory diarrhoea and a VIP-secreting tumour. Boureaut et al reported that diarrhoea was the presenting symptom in 16 out of 22 patients. In the remaining 6, diarrhoea developed after chemotherapy, a phenomenon referred to as ‘secondary VIP-secreting neuroblastic tumour’, and thought to be due to the release of VIP during chemotherapy-induced tumour lysis. Alternatively, a more generally accepted theory holds that chemotherapy concomitantly induces differentiation of (poorly differentiated) non-VIP-secreting neuroblastic tumours, as well as their capacity to secrete VIP [5, 8]. Third, a blood pressure over the 99th centile on repeated measurements should, especially in combination with the other signs and symptoms, should remind the clinician to the possibility of a neural crest tumour. The patient in our report also presented with hypertension, but the child reported by Swift et al. presented with a normal blood pressure [9]. Hypertension is however well known to be associated with neurogenic tumours in children [10]. Fourth, according to Iida et al, flushing may also direct to the diagnosis. In their series, flushing was noted in 7 of 31 cases. However, this is a transient sign and can easily be overlooked [8]. Last, sweating and waddling gait may also be present [6]. Our patient showed none of these signs.

In conclusion, intractable watery diarrhoea that persists during fasting in a young child should alert to the diagnosis of secretory diarrhoea. In this case a VIP secreting tumour, one of the most frequent causes of secretory diarrhoea in the developed world, should be ruled out, especially when concurrent hypertension is present. Timely diagnosis using plasma VIP levels, urinary catecholamine levels and MRI imaging should avoid unnecessary morbidity due to needless investigations and protracted diarrhoea.

Acknowledgments

We thankfully acknowledge Prof. Dr. An Billiau for the critical review of this paper.

Grants and Conflict of Interest

The authors have no conflict of interest or financial support to declare.


References▴Top 
  1. Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med. 1958;25(3):374-380.
    doi
  2. Bloom SR, Polak JM, Pearse AG. Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet. 1973;2(7819):14-16.
    doi
  3. Grier JF. WDHA (watery diarrhea, hypokalemia, achlorhydria) syndrome: clinical features, diagnosis, and treatment. South Med J. 1995;88(1):22-24.
    doi pubmed
  4. Modlin IM, Bloom SR, Mitchell SJ. Experimental evidence for vasoactive intestinal peptide as the cause of the watery diarrhea syndrome. Gastroenterology. 1978;75(6):1051-1054.
    pubmed
  5. Bourdeaut F, de Carli E, Timsit S, Coze C, Chastagner P, Sarnacki S, Delattre O, et al. VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Societe Francaise des Cancers de l'Enfant (SFCE). Pediatr Blood Cancer. 2009;52(5):585-590.
    doi pubmed
  6. Leleiko NS, Gee MS, Sadow PM. Case records of the Massachusetts General Hospital. Case 13-2010. An 18.5-month-old girl with watery diarrhea and poor weight gain. N Engl J Med. 2010;362(17):1619-1626.
    doi pubmed
  7. Murphy MS, Sibal A, Mann JR. Persistent diarrhoea and occult vipomas in children. BMJ. 2000;320(7248):1524-1526.
    doi pubmed
  8. Iida Y, Nose O, Kai H, Okada A, Mori T, Lee PK, Kakudo K, et al. Watery diarrhoea with a vasoactive intestinal peptide-producing ganglioneuroblastoma. Arch Dis Child. 1980;55(12):929-936.
    doi pubmed
  9. Swift PG, Bloom SR, Harris F. Watery diarrhoea and ganglioneuroma with secretion of vasoactive intestinal peptide. Arch Dis Child. 1975;50(11):896-899.
    doi pubmed
  10. Weinblatt ME, Heisel MA, Siegel SE. Hypertension in children with neurogenic tumors. Pediatrics. 1983;71(6):947-951.
    pubmed


This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Journal of Medical Cases is published by Elmer Press Inc.

 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.